Female Sexual Dysfunction.
Reed MA.
Clin Plast Surg. 2022 Oct;49(4):495-504. doi: 10.1016/j.cps.2022.06.009. Epub 2022 Aug 17.
Female sexual interest/arousal disorder: history of diagnostic considerations and their implications for clinical practice.
Witherow-Párkányi M.
Psychiatr Hung. 2022;37(2):133-149.
Female Sexual Dysfunction.
Clayton AH, Valladares Juarez EM.
Med Clin North Am. 2019 Jul;103(4):681-698. doi: 10.1016/j.mcna.2019.02.008.
Systemic testosterone for the treatment of female sexual interest and arousal disorder (FSIAD) in the postmenopause.
Ribera Torres L, Anglès-Acedo S, López Chardi L, Mension Coll E, Castelo-Branco C.
Gynecol Endocrinol. 2024 Dec;40(1):2364220. doi: 10.1080/09513590.2024.2364220. Epub 2024 Jun 24.
Female Sexual Dysfunction.
Clayton AH, Valladares Juarez EM.
Psychiatr Clin North Am. 2017 Jun;40(2):267-284. doi: 10.1016/j.psc.2017.01.004. Epub 2017 Mar 25.
Female sexual dysfunction.
Wright JJ, O'Connor KM.
Med Clin North Am. 2015 May;99(3):607-28. doi: 10.1016/j.mcna.2015.01.011. Epub 2015 Mar 6.
The clinical management of testosterone replacement therapy in postmenopausal women with hypoactive sexual desire disorder: a review.
Uloko M, Rahman F, Puri LI, Rubin RS.
Int J Impot Res. 2022 Nov;34(7):635-641. doi: 10.1038/s41443-022-00613-0. Epub 2022 Oct 5.
The complexities of female sexual arousal disorder: potential role of pharmacotherapy.
Basson R.
World J Urol. 2002 Jun;20(2):119-26. doi: 10.1007/s00345-002-0273-4. Epub 2002 May 8.
Sildenafil citrate for female sexual arousal disorder: a future possibility?
Schoen C, Bachmann G.
Nat Rev Urol. 2009 Apr;6(4):216-22. doi: 10.1038/nrurol.2009.25.
The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function.
Rosen R, Brown C, Heiman J, Leiblum S, Meston C, Shabsigh R, Ferguson D, D'Agostino R Jr.
J Sex Marital Ther. 2000 Apr-Jun;26(2):191-208. doi: 10.1080/009262300278597.
